Hepatic steatosis and fibrosis in chronic inflammatory bowel disease

Background and Purpose: Chronic inflammatory bowel diseases (IBD) frequently affect extraintestinal organs including the liver. Since limited evidence suggests the presence of liver disease in IBD patients, we studied the frequency of hepatic steatosis and fibrosis in these patients and characterize...

Full description

Saved in:
Bibliographic Details
Main Authors: Veltkamp, Claudia (Author) , Lan, Shuai (Author) , Korompoki, Eleni (Author) , Weiss, Karl-Heinz (Author) , Schmidt, Hartmut (Author) , Seitz, Helmut K. (Author)
Format: Article (Journal)
Language:English
Published: 6 May 2022
In: Journal of Clinical Medicine
Year: 2022, Volume: 11, Issue: 9, Pages: 1-10
ISSN:2077-0383
DOI:10.3390/jcm11092623
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/jcm11092623
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2077-0383/11/9/2623
Get full text
Author Notes:Claudia Veltkamp, Shuai Lan, Eleni Korompoki, Karl-Heinz Weiss, Hartmut Schmidt and Helmut K. Seitz

MARC

LEADER 00000caa a2200000 c 4500
001 1807546055
003 DE-627
005 20230427155713.0
007 cr uuu---uuuuu
008 220623s2022 xx |||||o 00| ||eng c
024 7 |a 10.3390/jcm11092623  |2 doi 
035 |a (DE-627)1807546055 
035 |a (DE-599)KXP1807546055 
035 |a (OCoLC)1341461424 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Veltkamp, Claudia  |d 1965-  |e VerfasserIn  |0 (DE-588)115359567  |0 (DE-627)691257930  |0 (DE-576)289834449  |4 aut 
245 1 0 |a Hepatic steatosis and fibrosis in chronic inflammatory bowel disease  |c Claudia Veltkamp, Shuai Lan, Eleni Korompoki, Karl-Heinz Weiss, Hartmut Schmidt and Helmut K. Seitz 
264 1 |c 6 May 2022 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.06.2022 
500 |a This article belongs to the Topic Liver Fibrosis and Cirrhosis 
520 |a Background and Purpose: Chronic inflammatory bowel diseases (IBD) frequently affect extraintestinal organs including the liver. Since limited evidence suggests the presence of liver disease in IBD patients, we studied the frequency of hepatic steatosis and fibrosis in these patients and characterized disease-related factors. Methods: In this retrospective, cross-sectional, hospital-based, single-center study, consecutive patients with Crohn’s disease (CD) and ulcerative colitis (UC) were included who had undergone routine abdominal ultrasound including transhepatic elastography. Hepatic steatosis was diagnosed by hyperechogenicity on B-mode ultrasound and by measuring controlled attenuation parameter (CAP). Hepatic fibrosis was assumed if transhepatic elastography yielded a stiffness > 7 kPa. Results: 132 patients (60% CD) with a median disease duration of 10 years were included. Steatosis assessed by B-mode ultrasound and CAP correlated well. Of the IBD patients, 30.3% had non-alcoholic fatty liver (NAFL). Factors associated with NAFL were age, BMI, duration of disease, as well as serum activities of aspartate-aminotransferase (AST) and gamma-glutamyl-transpeptidase (GGT). In multivariate analysis, only disease duration was independently associated with hepatic steatosis. Hepatic fibrosis was found in 10 (8%) of all IBD patients, predominantly in patients with CD (10/11). Conclusions: Pure hepatic steatosis is common in both CD and UC, whereas hepatic fibrosis occurs predominantly in CD patients. Association of disease duration with NAFLD suggests a contribution of IBD-related pathogenetic factors. Longitudinal studies are needed to better understand the impact of IBD on hepatic disorders. 
650 4 |a Crohn´s disease 
650 4 |a elastography 
650 4 |a hepatic fibrosis 
650 4 |a hepatic steatosis 
650 4 |a ulcerative colitis 
700 1 |a Lan, Shuai  |e VerfasserIn  |4 aut 
700 1 |a Korompoki, Eleni  |e VerfasserIn  |4 aut 
700 1 |a Weiss, Karl-Heinz  |e VerfasserIn  |4 aut 
700 1 |a Schmidt, Hartmut  |e VerfasserIn  |4 aut 
700 1 |a Seitz, Helmut K.  |d 1950-  |e VerfasserIn  |0 (DE-588)141662476  |0 (DE-627)704035685  |0 (DE-576)325212503  |4 aut 
773 0 8 |i Enthalten in  |t Journal of Clinical Medicine  |d Basel : MDPI, 2012  |g 11(2022), 9, Artikel-ID 2623, Seite 1-10  |h Online-Ressource  |w (DE-627)718632478  |w (DE-600)2662592-1  |w (DE-576)365782718  |x 2077-0383  |7 nnas  |a Hepatic steatosis and fibrosis in chronic inflammatory bowel disease 
773 1 8 |g volume:11  |g year:2022  |g number:9  |g elocationid:2623  |g pages:1-10  |g extent:10  |a Hepatic steatosis and fibrosis in chronic inflammatory bowel disease 
856 4 0 |u https://doi.org/10.3390/jcm11092623  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2077-0383/11/9/2623  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220623 
993 |a Article 
994 |a 2022 
998 |g 141662476  |a Seitz, Helmut K.  |m 141662476:Seitz, Helmut K.  |d 50000  |e 50000PS141662476  |k 0/50000/  |p 6  |y j 
999 |a KXP-PPN1807546055  |e 4154818104 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"id":{"issn":["2077-0383"],"zdb":["2662592-1"],"eki":["718632478"]},"origin":[{"dateIssuedDisp":"2012-","dateIssuedKey":"2012","publisher":"MDPI","publisherPlace":"Basel"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Journal of Clinical Medicine","title":"Journal of Clinical Medicine","subtitle":"open access journal"}],"language":["eng"],"recId":"718632478","note":["Gesehen am 12.06.20"],"disp":"Hepatic steatosis and fibrosis in chronic inflammatory bowel diseaseJournal of Clinical Medicine","type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"text":"11(2022), 9, Artikel-ID 2623, Seite 1-10","volume":"11","extent":"10","year":"2022","pages":"1-10","issue":"9"},"pubHistory":["1.2012 -"]}],"physDesc":[{"extent":"10 S."}],"name":{"displayForm":["Claudia Veltkamp, Shuai Lan, Eleni Korompoki, Karl-Heinz Weiss, Hartmut Schmidt and Helmut K. Seitz"]},"id":{"doi":["10.3390/jcm11092623"],"eki":["1807546055"]},"origin":[{"dateIssuedDisp":"6 May 2022","dateIssuedKey":"2022"}],"language":["eng"],"recId":"1807546055","note":["Gesehen am 23.06.2022","This article belongs to the Topic Liver Fibrosis and Cirrhosis"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"roleDisplay":"VerfasserIn","display":"Veltkamp, Claudia","role":"aut","family":"Veltkamp","given":"Claudia"},{"roleDisplay":"VerfasserIn","display":"Lan, Shuai","role":"aut","family":"Lan","given":"Shuai"},{"given":"Eleni","family":"Korompoki","role":"aut","roleDisplay":"VerfasserIn","display":"Korompoki, Eleni"},{"role":"aut","display":"Weiss, Karl-Heinz","roleDisplay":"VerfasserIn","given":"Karl-Heinz","family":"Weiss"},{"family":"Schmidt","given":"Hartmut","display":"Schmidt, Hartmut","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Seitz, Helmut K.","given":"Helmut K.","family":"Seitz"}],"title":[{"title_sort":"Hepatic steatosis and fibrosis in chronic inflammatory bowel disease","title":"Hepatic steatosis and fibrosis in chronic inflammatory bowel disease"}]} 
SRT |a VELTKAMPCLHEPATICSTE6202